ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

HYPR Hyperfine Inc

0,8139
-0,0133 (-1,61%)
Dernière mise à jour : 18:13:47
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Hyperfine Inc HYPR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,0133 -1,61% 0,8139 18:13:47
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,85 0,8101 0,85 0,8272
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202422:05BWHyperfine, Inc. to Announce First Quarter 2024 Financial..
23/4/202415:00BWHyperfine, Inc. Takes the Stage at ISMRM with Seventeen..
17/4/202415:00BWLeading Institutions Enroll First Alzheimer’s Patients..
21/3/202421:05GLOBEHyperfine, Inc. Reports Fourth Quarter and Full Year 2023..
21/3/202412:26IHMARKETNEWSU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
12/3/202414:00BWHyperfine, Inc. Collaborates with King’s College London to..
07/3/202422:30BWHyperfine, Inc. to Announce Fourth Quarter and Full Year..
28/2/202422:30BWHyperfine, Inc. to Present at the Oppenheimer 34th Annual..
21/2/202415:00BWHyperfine, Inc. Announces Collaboration with Athletic Heart..
16/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202414:00BWHyperfine, Inc. Celebrates Breadth of Swoop® System Data..
09/1/202415:00BWHyperfine, Inc. Launches AI-powered Brain Imaging Software..
24/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/11/202300:20EDGAR2Form 3/A - Initial statement of beneficial ownership of..
20/11/202315:00BWHyperfine, Inc. Announces Presentations on Clinical..
18/11/202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:00BWHyperfine, Inc. to Present at the Piper Sandler 35th Annual..
09/11/202322:58EDGAR2Form 8-K - Current report
09/11/202322:43EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:10EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEHyperfine, Inc. Reports Third Quarter 2023 Financial Results
02/11/202314:15BWObservational Study Finds That Hyperfine, Inc. Portable MR..
19/10/202322:05BWHyperfine, Inc. to Announce Third Quarter Financial Results..
10/10/202322:05BWHyperfine, Inc. Announces Promotions of Two Key Clinical..
09/10/202315:00BWHyperfine, Inc. Receives FDA Clearance for Updated..
03/10/202322:07EDGAR2Form 8-K - Current report
07/9/202322:05BWHyperfine, Inc. to Present at Gilmartin Group Emerging..
17/8/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:11EDGAR2Form 8-K - Current report
14/8/202322:05GLOBEHyperfine, Inc. Reports Second Quarter 2023 Financial..
09/8/202315:00BWEnrollment Completed for HOPE PMR Pediatric Hydrocephalus..
24/7/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202322:05BWHyperfine, Inc. to Announce Second Quarter Financial Results..
18/7/202322:19EDGAR2Form 8-K - Current report
18/7/202322:05BWHyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D...
11/7/202315:00BWHyperfine, Inc. Launches Observational Study to Define New..
08/6/202315:00BWHyperfine, Inc. and the International Society for Magnetic..
18/5/202315:00BWHyperfine, Inc. Receives Grant for an Additional Three Years..
11/5/202322:05GLOBEHyperfine, Inc. Reports First Quarter 2023 Financial Results

Dernières Valeurs Consultées

Delayed Upgrade Clock